-
Je něco špatně v tomto záznamu ?
Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands
E. Hrubá, J. Vondráček, H. Líbalová, J. Topinka, V. Bryja, K. Souček, M. Machala,
Jazyk angličtina Země Nizozemsko
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- aparát dělícího vřeténka účinky léků MeSH
- benzopyren toxicita MeSH
- buněčný cyklus účinky léků MeSH
- časové faktory MeSH
- karcinogeny životního prostředí toxicita MeSH
- karcinom metabolismus MeSH
- lidé MeSH
- ligandy MeSH
- mutageny toxicita MeSH
- nádorové buněčné linie MeSH
- nádory prostaty metabolismus MeSH
- oprava DNA účinky léků MeSH
- polychlorované dibenzodioxiny toxicita MeSH
- proteiny Wnt genetika metabolismus MeSH
- protoonkogenní proteiny genetika metabolismus MeSH
- receptory aromatických uhlovodíků agonisté MeSH
- regulace genové exprese u nádorů účinky léků MeSH
- replikace DNA účinky léků MeSH
- sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů MeSH
- stanovení celkové genové exprese MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
Carcinogenic polycyclic aromatic hydrocarbons (PAHs) are known as efficient mutagens and ligands of the aryl hydrocarbon receptor (AhR), which has been suggested to play an important role in prostate carcinogenesis. In order to evaluate the complex relationship between the genotoxicity and the AhR-mediated activity of PAHs in prostate cells, we selected benzo[a]pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), as model genotoxic and nongenotoxic AhR ligands, respectively, to explore global changes in gene expression in LNCaP cells by microarray analysis. We identified 112 genes that were differentially expressed in cells treated for 24h with BaP, TCDD or both compounds. Our data indicated that the impacts of BaP and TCDD on transcriptome of LNCaP cells significantly overlap, since over 64% of significantly up-regulated genes and 47% of down-regulated genes were similarly affected by both AhR ligands. This suggested that the activation of AhR played a prominent role in the nongenotoxic effects of BaP in the prostate carcinoma cell model LNCaP. Both AhR ligands suppressed expression of genes associated with cell cycle progression, DNA replication, spindle assembly checkpoint or DNA repair, which probably occurred secondary to inhibition of cell cycle progression. In contrast, we identified Wnt5a, an important regulator of prostate cancer progression, to be induced as early as 6h after exposure to both AhR ligands. The AhR ligand-induced Wnt5a upregulation, together with other observed alterations of gene expression, may further contribute to enhanced cell plasticity of prostate carcinoma cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028141
- 003
- CZ-PrNML
- 005
- 20121210100911.0
- 007
- ta
- 008
- 120817e20110723ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.toxlet.2011.07.011 $2 doi
- 035 __
- $a (PubMed)21802500
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hrubá, Eva $u Department of Toxicology, Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno, Czech Republic.
- 245 10
- $a Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands / $c E. Hrubá, J. Vondráček, H. Líbalová, J. Topinka, V. Bryja, K. Souček, M. Machala,
- 520 9_
- $a Carcinogenic polycyclic aromatic hydrocarbons (PAHs) are known as efficient mutagens and ligands of the aryl hydrocarbon receptor (AhR), which has been suggested to play an important role in prostate carcinogenesis. In order to evaluate the complex relationship between the genotoxicity and the AhR-mediated activity of PAHs in prostate cells, we selected benzo[a]pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), as model genotoxic and nongenotoxic AhR ligands, respectively, to explore global changes in gene expression in LNCaP cells by microarray analysis. We identified 112 genes that were differentially expressed in cells treated for 24h with BaP, TCDD or both compounds. Our data indicated that the impacts of BaP and TCDD on transcriptome of LNCaP cells significantly overlap, since over 64% of significantly up-regulated genes and 47% of down-regulated genes were similarly affected by both AhR ligands. This suggested that the activation of AhR played a prominent role in the nongenotoxic effects of BaP in the prostate carcinoma cell model LNCaP. Both AhR ligands suppressed expression of genes associated with cell cycle progression, DNA replication, spindle assembly checkpoint or DNA repair, which probably occurred secondary to inhibition of cell cycle progression. In contrast, we identified Wnt5a, an important regulator of prostate cancer progression, to be induced as early as 6h after exposure to both AhR ligands. The AhR ligand-induced Wnt5a upregulation, together with other observed alterations of gene expression, may further contribute to enhanced cell plasticity of prostate carcinoma cells.
- 650 _2
- $a benzopyren $x toxicita $7 D001564
- 650 _2
- $a karcinogeny životního prostředí $x toxicita $7 D002274
- 650 _2
- $a karcinom $x metabolismus $7 D002277
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a oprava DNA $x účinky léků $7 D004260
- 650 _2
- $a replikace DNA $x účinky léků $7 D004261
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a aparát dělícího vřeténka $x účinky léků $7 D008941
- 650 _2
- $a mutageny $x toxicita $7 D009153
- 650 _2
- $a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
- 650 _2
- $a nádory prostaty $x metabolismus $7 D011471
- 650 _2
- $a protoonkogenní proteiny $x genetika $x metabolismus $7 D011518
- 650 _2
- $a receptory aromatických uhlovodíků $x agonisté $7 D018336
- 650 _2
- $a polychlorované dibenzodioxiny $x toxicita $7 D000072317
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a proteiny Wnt $x genetika $x metabolismus $7 D051153
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vondráček, Jan
- 700 1_
- $a Líbalová, Helena
- 700 1_
- $a Topinka, Jan
- 700 1_
- $a Bryja, Vítězslav
- 700 1_
- $a Souček, Karel
- 700 1_
- $a Machala, Miroslav
- 773 0_
- $w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 206, č. 2 (20110723), s. 178-88
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21802500 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210100948 $b ABA008
- 999 __
- $a ok $b bmc $g 950183 $s 785487
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 206 $c 2 $d 178-88 $e 20110723 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a Pubmed-20120817/11/04